Jolessa Kit
Product Images NDC 0555-9123

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Jolessa (NDC 0555-9123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Jolessa Levonorgestrel Ethinyl Estradiol Kit 1

Illustrative diagram showing two Jolessa kit blister packs for oral contraceptive tablets by Teva Pharmaceuticals USA, Inc., each with 91 tablets arranged by day of the week. The active ingredients Levonorgestrel and Ethinyl Estradiol are indicated on the packaging image.*

FDA Label Image

Jolessa Levonorgestrel Ethinyl Estradiol Kit 10

Packaging label for Jolessa kit containing levonorgestrel and ethinyl estradiol tablets, each 0.15 mg/0.03 mg. The kit includes 3 extended-cycle tablet dispensers with 91 tablets each for a 91-day regimen. Labeler is Teva Pharmaceuticals USA, Inc. The label features dosage information and a QR code for additional product details. The background is pink with vertical stripes.*

FDA Label Image

Jolessa Levonorgestrel Ethinyl Estradiol Kit 11

Jolessa (levonorgestrel/ethinyl estradiol) tablets 0.15 mg/0.03 mg kit packaging label. The label indicates a 91-day regimen supplied in three extended-cycle tablet dispensers containing 91 tablets each. Labeler is Teva Pharmaceuticals USA, Inc. The packaging features pink and white vertical stripes with dosage and storage information, NDC 0555-9123, and barcode visible.*

FDA Label Image

Jolessa Levonorgestrel Ethinyl Estradiol Kit 2

Jolessa (levonorgestrel / ethinyl estradiol) tablets 0.15 mg / 0.03 mg in a 91-day kit pack. The label shows a blister card layout with circular tablet slots arranged in a weekly format labeled Sunday through Saturday, including an extended row at the bottom. The pack includes directions to see lot and expiration dates on the reverse side and displays a QR code on the right edge. Labeler is Teva Pharmaceuticals USA, Inc.*

FDA Label Image

Jolessa Levonorgestrel Ethinyl Estradiol Kit 3

A forest plot chart depicting effect estimates from multiple studies comparing 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use.' The studies listed include NICHD Women's Care Study, French E3N cohort, Shanghai Women's Health Study, Nurses' Health Study II, Oxford Family Planning Study, and Danish Sex Hormone Register Study, with effect estimates shown as points with confidence intervals on a horizontal axis labeled 'Effect Estimate.' Numeric values for odds ratios (OR), relative risks (RR), and hazard ratios (HR) are shown beside each study.*

FDA Label Image

Jolessa Levonorgestrel Ethinyl Estradiol Kit 4

Chemical structure diagram of Levonorgestrel, showing its molecular framework with labeled functional groups and stereochemistry.*

FDA Label Image

Jolessa Levonorgestrel Ethinyl Estradiol Kit 5

Chemical structure diagram of the active ingredient Ethinyl Estradiol, showing its molecular configuration with labeled functional groups and bonds.*

FDA Label Image

Jolessa Levonorgestrel Ethinyl Estradiol Kit 6

A vertical diagram illustrating the relative effectiveness of various birth control methods based on pregnancies per 100 women per year. The chart shows birth control methods ranked from fewer pregnancies (implants, injections, intrauterine devices, sterilization) to more pregnancies (no birth control), with categories including birth control pills, skin patch, vaginal ring, condoms, diaphragm, and behavioral methods listed in between.*

FDA Label Image

Jolessa Levonorgestrel Ethinyl Estradiol Kit 7

Jolessa kit containing levonorgestrel and ethinyl estradiol tablets, 0.15 mg/0.03 mg dosage. The kit features two blister cards for a 91-day regimen, each card organized in a weekly layout from Sunday to Saturday, with circular tablets shown. Labeler is Teva Pharmaceuticals USA, Inc.*

FDA Label Image

Jolessa Levonorgestrel Ethinyl Estradiol Kit 8

Jolessa (levonorgestrel/ethinyl estradiol) tablets, 0.15 mg / 0.03 mg, presented as a 91-day oral contraceptive kit with tablet regimen organized by days of the week. The label includes days labeled from Sunday to Saturday and circular tablet compartments for daily use.*

FDA Label Image

Jolessa Levonorgestrel Ethinyl Estradiol Kit 9

Jolessa kit containing levonorgestrel 0.15 mg and ethinyl estradiol 0.03 mg tablets, designed as a 91-day regimen. The blister pack features 91 circular tablet compartments arranged by day of the week (Sunday to Saturday). The label includes storage instructions and the Teva Pharmaceuticals USA, Inc. branding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.